Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04675346
What this trial is testing

Exploring Unmet Needs and Attitudes to Skin Self-examination in Melanoma Survivors

Who this might be right for
Melanoma, Stage IMelanoma Stage IIIMelanoma, Stage II
Oxford University Hospitals NHS Trust 252
Not applicableActive Not RecruitingNCT01942603
What this trial is testing

Minimal SN Tumor Burden

Who this might be right for
Cutaneous Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 296
Early research (Phase 1)Ended earlyNCT03425461
What this trial is testing

Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma

Who this might be right for
Metastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7+3 more
Jonsson Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)UnknownNCT00492505
What this trial is testing

Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma

Who this might be right for
Melanoma (Skin)
San Diego Pacific Oncology & Hematology Associates 200
Early research (Phase 1)Study completedNCT00003224
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
University of Virginia 22
Early research (Phase 1)Study completedNCT02676869
What this trial is testing

Phase 1 Study of IMP321 (Eftilagimod Alpha) Adjuvant to Anti-PD-1 Therapy in Unresectable or Metastatic Melanoma

Who this might be right for
Stage IV MelanomaStage III Melanoma
Immutep Australia Pty. Ltd. 24
Large-scale testing (Phase 3)UnknownNCT00779714
What this trial is testing

Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC

Who this might be right for
Melanoma
University of Wuerzburg 360
Testing effectiveness (Phase 2)Study completedNCT00089193
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Craig L Slingluff, Jr
Early research (Phase 1)Study completedNCT01176474
What this trial is testing

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 73
Large-scale testing (Phase 3)UnknownNCT00006249
What this trial is testing

Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 1,258
Not applicableUnknownNCT05171374
What this trial is testing

PRospective Evaluation of Clinical Outcomes in Patients With metAsTatIс melanOma Treated With dabrafeNib and trAmetinib in reaL practicE

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVMelanoma
MelanomaPRO, Russia 500
Testing effectiveness (Phase 2)Study completedNCT00938223
What this trial is testing

Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 51
Early research (Phase 1)Study completedNCT01657591
What this trial is testing

Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 21
Testing effectiveness (Phase 2)Study completedNCT03541148
What this trial is testing

Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma, Stage IIMalignant Cutaneous MelanomaCutaneous Melanoma, Stage III
Catalysis SL 20
Testing effectiveness (Phase 2)Study completedNCT00005615
What this trial is testing

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 24
Large-scale testing (Phase 3)Study completedNCT03551626
What this trial is testing

Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes

Who this might be right for
Malignant Melanoma
Novartis Pharmaceuticals 552
Testing effectiveness (Phase 2)Study completedNCT00031733
What this trial is testing

Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 60
Early research (Phase 1)Study completedNCT00655655
What this trial is testing

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+17 more
Mayo Clinic 96
Testing effectiveness (Phase 2)Study completedNCT03200847
What this trial is testing

Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaAdvanced Melanoma
University of Colorado, Denver 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06708455
What this trial is testing

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

Who this might be right for
Malignant Melanoma With MetastasisMalignant MelanomaMalignant Melanoma Stage IIIc+1 more
Rapa Therapeutics LLC 65
Next Page